Sociedad Química y Minera de Chile S.A.

- The transcript does not mention any current or planned fundraising activities through debt or equity. - No references were made to issuing new shares, bond offerings, or other capital raising initiatives. - Capital expenditure for projects, such as the Mt Holland concentrator expansion, is planned and partially budgeted (around $200 million between 2025 and 2027) but no mention of raising funds via debt or equity for this. - The company’s investment and expansion plans appear to be funded through internal cash flow and existing financial resources. - No discussion of share buybacks or capital restructuring related to funding was noted.

- SQM plans a final investment decision this year (2026) for the expansion of the Mt Holland mine and concentrator, targeting mid-year Board approval from both Wesfarmers and SQM. - Engineering studies are progressing well, aiming for above 30% advanced engineering by mid-2026, and around 50% progress in concentrator engineering. - Approximately $200 million CapEx is allocated for the Mt Holland concentrator expansion within the 2025-2027 projection, expected in 2027. - The Chilean lithium chemical plant expansion in Antofagasta is delayed to 2028 due to optimization projects, but total production is not affected. - Iodine sector investments include the seawater pipeline project in the Tarapacá region, expected to increase production capacity beyond 17,000 metric tons per year. - Exploration drilling programs planned for 2026 include Mount Roberts and Northern Territories in Australia, as well as Stage 2 exploration in Namibia.

- SQM targets strong sales volume growth in lithium, expecting a 10% increase on an LCE basis in 2026. - Production expected to reach close to 260,000 tons LCE in 2026, up from 234,000 tons in 2025. - Sales volumes for lithium in Q1 2026 forecast to surpass Q1 2025 by more than 15%, a record. - Ramp-up of concentrator at Mount Holland to support production at full capacity in 2026. - Kwinana refinery ramp-up issues expected to be resolved by mid-2026, with volume growth leaning towards spodumene concentrate. - Iodine market demand expected to grow around 3% in 2026, with sales volumes stable to slightly increasing. - Specialty Plant Nutrition volume growth expected between 2%-4% in 2026 amid stable pricing. - Expansion projects, e.g., seawater pipeline in Tarapaca, will unlock incremental production capacity for iodine and lithium. - CapEx for Mt. Holland concentrator expansion projected at around $200 million (2025-27). - Overall, SQM is entering 2026 with strong operational momentum and improving market conditions.

- SQM expects continued strong operational momentum entering 2026 with improved lithium market conditions and strength in iodine and specialty plant nutrition sectors. - Lithium sales volume targeted to increase by approximately 10% in 2026, with production close to 260,000 tons LCE, driven by expansions and efficiency improvements. - Operating at full capacity in Chile and China, with flexibility in product mix between lithium carbonate and hydroxide. - The Kwinana refinery ramp-up to extend into 2027, prompting heavier reliance on spodumene concentrate in 2026 sales. - CapEx of around $200 million allocated for concentrator expansion at Mount Holland in 2027. - Earnings expected to benefit from strong lithium pricing, with Q1 2026 lithium sales prices substantially higher than Q4 2025. - Dividend payments to Codelco expected in April 2026, related to net income from lithium production portion. - Iodine market expected to grow ~3% in 2026, sustaining profitability. - Supply expansions and new projects in iodine and lithium to support future growth and profits.

- Over 80% of lithium sales volume for 2026 is already contracted, leaving some space for spot sales to maximize margins. - There is strong appetite and inquiries from Chinese and Asia Pacific customers for lithium volumes, but SQM is managing a diversified customer portfolio carefully. - Sales volume in Q1 2026 is expected to surpass Q1 2025 by more than 15%, aiming for a record quarter. - Total expected lithium sales growth for 2026 is around 10% on an LCE basis, aligned with production capacity increases. - The ramp-up challenges at the Kwinana refinery mean sales volumes in 2026 will lean more on spodumene concentrate, providing flexibility. - No specific figures provided on other product lines' order backlog, but the company emphasizes strong operational momentum and contracted sales.